Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Assessment of Faecal Microbiota Transplant Stability in Deep-Freeze Conditions: A 12-Month Ex Vivo Viability Analysis

H. Soukupova, V. Rehorova, I. Cibulkova, F. Duska

. 2024 ; 38 (7) : e25023. [pub] 20240327

Language English Country United States

Document type Journal Article

Grant support
Univerzita Karlova v Praze
Donatio Intensivistam Endowement Fund
FNKV University Hospital

BACKGROUND: Faecal microbiota transplantation (FMT) is an established treatment for Clostridioides difficile infection and is under investigation for other conditions. The availability of suitable donors and the logistics of fresh stool preparation present challenges, making frozen, biobanked stools an attractive alternative. AIMS: This study aimed to evaluate the long-term viability of bacterial populations in faecal samples stored at -80°C for up to 12 months, supporting the feasibility of using frozen grafts for FMT. METHODS: Fifteen faecal samples from nine healthy donors were processed, mixed with cryoprotectants and stored at -80°C. Samples were assessed at baseline and after 3, 6 and 12 months using quantitative culturing methods to determine the concentration of live bacteria. RESULTS: Quantitative analysis showed no significant decrease in bacterial viability over the 12-month period for both aerobic and anaerobic cultures (p = 0.09). At all timepoints, the coefficients of variability in colony-forming unit (CFU) counts were greater between samples (102 ± 21% and 100 ± 13% for aerobic and anaerobic cultures, respectively) than the variability between measurements of the same sample (30 ± 22% and 30 ± 19%). CONCLUSIONS: The study confirmed that faecal microbiota can be preserved with high viability in deep-freeze storage for up to a year, making allogenic FMT from biobanked samples a viable and safer option for patients. However, a multidonor approach may be beneficial to mitigate the risk of viability loss in any single donor sample.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24014422
003      
CZ-PrNML
005      
20240905134017.0
007      
ta
008      
240725s2024 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1002/jcla.25023 $2 doi
035    __
$a (PubMed)38544348
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Soukupova, Hana $u Department of Microbiology, The Third Faculty of Medicine, Charles University and Kralovske Vinohrady University Hospital, Prague, Czech Republic
245    10
$a Assessment of Faecal Microbiota Transplant Stability in Deep-Freeze Conditions: A 12-Month Ex Vivo Viability Analysis / $c H. Soukupova, V. Rehorova, I. Cibulkova, F. Duska
520    9_
$a BACKGROUND: Faecal microbiota transplantation (FMT) is an established treatment for Clostridioides difficile infection and is under investigation for other conditions. The availability of suitable donors and the logistics of fresh stool preparation present challenges, making frozen, biobanked stools an attractive alternative. AIMS: This study aimed to evaluate the long-term viability of bacterial populations in faecal samples stored at -80°C for up to 12 months, supporting the feasibility of using frozen grafts for FMT. METHODS: Fifteen faecal samples from nine healthy donors were processed, mixed with cryoprotectants and stored at -80°C. Samples were assessed at baseline and after 3, 6 and 12 months using quantitative culturing methods to determine the concentration of live bacteria. RESULTS: Quantitative analysis showed no significant decrease in bacterial viability over the 12-month period for both aerobic and anaerobic cultures (p = 0.09). At all timepoints, the coefficients of variability in colony-forming unit (CFU) counts were greater between samples (102 ± 21% and 100 ± 13% for aerobic and anaerobic cultures, respectively) than the variability between measurements of the same sample (30 ± 22% and 30 ± 19%). CONCLUSIONS: The study confirmed that faecal microbiota can be preserved with high viability in deep-freeze storage for up to a year, making allogenic FMT from biobanked samples a viable and safer option for patients. However, a multidonor approach may be beneficial to mitigate the risk of viability loss in any single donor sample.
650    _2
$a lidé $7 D006801
650    12
$a fekální transplantace $x metody $7 D000069467
650    12
$a feces $x mikrobiologie $7 D005243
650    12
$a mikrobiální viabilita $7 D050296
650    _2
$a zmrazování $7 D005615
650    _2
$a kryoprezervace $x metody $7 D015925
650    _2
$a mužské pohlaví $7 D008297
655    _2
$a časopisecké články $7 D016428
700    1_
$a Rehorova, Veronika $u Department of Anaesthesia and Intensive Care Medicine, The Third Faculty of Medicine, Charles University and Kralovske Vinohrady University Hospital, Prague, Czech Republic
700    1_
$a Cibulkova, Ivana $u Division of Gastroenterology, Department of Medicine, Kralovske Vinohrady University Hospital, Prague, Czech Republic
700    1_
$a Duska, Frantisek $u Department of Anaesthesia and Intensive Care Medicine, The Third Faculty of Medicine, Charles University and Kralovske Vinohrady University Hospital, Prague, Czech Republic $1 https://orcid.org/0000000315594078 $7 mzk2007386027
773    0_
$w MED00009990 $t Journal of clinical laboratory analysis $x 1098-2825 $g Roč. 38, č. 7 (2024), s. e25023
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38544348 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240725 $b ABA008
991    __
$a 20240905134011 $b ABA008
999    __
$a ok $b bmc $g 2143907 $s 1226288
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 38 $c 7 $d e25023 $e 20240327 $i 1098-2825 $m Journal of clinical laboratory analysis $n J Clin Lab Anal $x MED00009990
GRA    __
$p Univerzita Karlova v Praze
GRA    __
$p Donatio Intensivistam Endowement Fund
GRA    __
$p FNKV University Hospital
LZP    __
$a Pubmed-20240725

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...